Healthpeak Properties (NYSE:DOC) Given New $24.00 Price Target at Mizuho

Healthpeak Properties (NYSE:DOC) had its price objective increased by analysts at Mizuho from $21.00 to $24.00 in a research report issued on Monday,Benzinga reports. The brokerage currently has an “outperform” rating on the real estate investment trust’s stock. Mizuho’s price objective indicates a potential upside of 9.82% from the company’s previous close.

Several other equities research analysts have also weighed in on DOC. Scotiabank lifted their price objective on Healthpeak Properties from $19.00 to $21.00 and gave the stock a “sector perform” rating in a report on Wednesday, May 27th. Royal Bank Of Canada boosted their price objective on Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a research note on Thursday, May 14th. Robert W. Baird increased their target price on shares of Healthpeak Properties from $19.00 to $21.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Wall Street Zen upgraded shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Sunday, May 10th. Finally, Wells Fargo & Company lifted their target price on shares of Healthpeak Properties from $18.00 to $20.00 and gave the stock an “equal weight” rating in a research note on Monday, June 1st. Four research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $20.19.

Healthpeak Properties Price Performance

Healthpeak Properties stock opened at $21.85 on Monday. The business’s 50 day simple moving average is $19.54 and its 200 day simple moving average is $17.85. Healthpeak Properties has a 12 month low of $15.70 and a 12 month high of $21.98. The company has a market cap of $15.07 billion, a price-to-earnings ratio of 68.30, a PEG ratio of 3.41 and a beta of 1.02. The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15.

Healthpeak Properties (NYSE:DOC) last released its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. The business had revenue of $752.95 million during the quarter, compared to the consensus estimate of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The business’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period last year, the business posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Sell-side analysts forecast that Healthpeak Properties will post 1.75 EPS for the current year.

Insider Buying and Selling at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the transaction, the insider directly owned 7,636 shares in the company, valued at approximately $148,520.20. The trade was a 59.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.23% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the stock. New York Life Investment Management LLC increased its holdings in Healthpeak Properties by 65.8% during the 4th quarter. New York Life Investment Management LLC now owns 156,086 shares of the real estate investment trust’s stock worth $2,510,000 after acquiring an additional 61,952 shares during the period. Northside Capital Management LLC boosted its holdings in Healthpeak Properties by 47.7% in the 4th quarter. Northside Capital Management LLC now owns 472,337 shares of the real estate investment trust’s stock valued at $7,595,000 after purchasing an additional 152,579 shares during the period. Russell Investments Group Ltd. grew its position in shares of Healthpeak Properties by 176.4% during the 3rd quarter. Russell Investments Group Ltd. now owns 3,063,569 shares of the real estate investment trust’s stock valued at $58,663,000 after purchasing an additional 1,955,273 shares in the last quarter. Baillie Gifford & Co. grew its position in shares of Healthpeak Properties by 613.2% during the 4th quarter. Baillie Gifford & Co. now owns 367,256 shares of the real estate investment trust’s stock valued at $5,905,000 after purchasing an additional 315,763 shares in the last quarter. Finally, Oak Thistle LLC purchased a new position in shares of Healthpeak Properties during the 4th quarter valued at $3,938,000. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.